Stem cell extraction from the umbilical cord is not new, as a matter of fact it has a proven track record as a rich source of progenitor stem cells both from the endothelium (from which Human Umbilical Vein Endothelial Cells- HUVECs- are obtained) as well as from the contained cord blood which is already being banked in numerous public and private centres around the world as a source of autologous stem cells for the future.

The addition of mesenchymal and epithelial stem cells from the cord lining strengthens its versatility.

Look at some of the key advantages of the cord lining;
• Medical waste
• Non invasive
• Zero morbidity to mother and infant
• Ease of processing as compared with other stem cell sources
• Non embryonic source with no or limited ethical controversies and barriers
• Two important cell types isolated from a single tissue
• Stem cells behaviour closer to embryonic than adult stem cells yet having the edge of being non-embryonic
• Virtually endless supply
• High yield